Effects of combined use of a patient-tracking system and a smart drug-dispenser on the overall risk of the diagnostic-therapeutic process

Clinical risk and the incidence of adverse event are relevant problems, that have been subject of many studies during last years. The objective of this study is to assess the potential clinical risk reduction obtained with the combined implementation in the diagnostic-therapeutic process work- flows of a patient-tracking system and a smart drug-dispenser, both based on RFId technology. The study will be driven by a multidimensional FMECA, considering in the risk analysis all the subjects involved in the diagnostic-therapeutic process, not only the dimension of patient safety indeed, but also medical staff dimension and structure (hospital facility) dimension. Mitigation interventions are found and they often result in a further development and enhancement of the functionality of the two studied RFId systems.